Skip to main content

Sexually Transmitted Diseases: Vaccination

Volume 458: debated on Wednesday 14 March 2007

To ask the Secretary of State for Health if she will ensure that the recommendations of the Joint Committee on Vaccination and Immunisation on a human papilloma virus national immunisation programme are implemented within the school year 2007-08. (124115)

The Joint Committee on Vaccination and Immunisation (JCVI) human papilloma virus (HPV) subgroup met on 28 February to review the available information on the protective effect of the vaccine against cervical cancer, and the safety of HPV vaccines. Further work is ongoing to evaluate whether the vaccine is considered to be a cost-effective prevention of cervical cancer; and the impact that HPV vaccine may have on genital warts.

The subgroup’s advice will be reported to the main JCVI committee for further discussion. No decisions will be taken on introducing these vaccines into the immunisation programme until the main JCVI present their advice to Ministers for their consideration.

To ask the Secretary of State for Health what assessment she has made of the potential impact on NHS spending of a national human papilloma virus types 6, 11, 16 and 18 immunisation programme for (a) 12-year-old girls, (b) 12 to 16-year-old girls and (c) 12 to 16-year-old girls and boys. (124121)

This work is currently being undertaken for the Joint Committee on Vaccination and Immunisation’s consideration.